id: catechin_hydrate_administration_to_pancreatic_fibrosis
name: Catechin Hydrate Administration → Pancreatic Fibrosis
from_node:
  node_id: catechin_hydrate_administration
  node_name: Catechin Hydrate Administration
to_node:
  node_id: pancreatic_fibrosis
  node_name: Pancreatic Fibrosis
direction: negative
category: biological
mechanism_pathway:
- 'Step 1: Catechin hydrate inhibits TGF-β/Smad2 signaling pathway activation in pancreatic
  tissue'
- 'Step 2: Suppression of Smad2 activation prevents pancreatic stellate cell (PSC)
  activation'
- 'Step 3: Reduced PSC activation decreases production of extracellular matrix components
  including fibronectin 1 and collagens'
- 'Step 4: Decreased extracellular matrix deposition prevents pancreatic fibrosis
  development'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: Bitna Kweon et al. 2023. "Catechin hydrate ameliorates cerulein‑induced
    chronic pancreatitis via the inactivation of TGF‑β/Smad2 signaling.." *Molecular
    medicine reports*. https://doi.org/10.3892/mmr.2023.13095
last_updated: '2025-12-02'
version: '1.0'
llm_metadata:
  extracted_by: claude-sonnet-4-5-20250929
  extraction_date: '2025-12-02T18:12:07.231574'
  batch_id: msgbatch_01AKnPJgzm7Fk9qubgAz9GaD
moderators:
- name: catechin_dose
  direction: strengthens
  strength: moderate
  description: Multiple doses tested (1, 5, and 10 mg/kg) with prophylactic effects;
    5 mg/kg used for therapeutic assessment
- name: timing_of_administration
  direction: strengthens
  strength: moderate
  description: Both prophylactic (1 hour before cerulein) and therapeutic (after cerulein
    injection for 1-2 weeks) administration showed effects
_source_file: /Users/mauriceelhelou/Library/CloudStorage/OneDrive-HarvardUniversity/New
  folder (2)/healthsystems/mechanism-bank/mechanisms/biological/catechin_hydrate_administration_to_pancreatic_fibrosis.yaml
_category: biological
